Superagers, whose brains remain youthful well into old age, appear to be more sociable and have a greater number of ...

Some people’s brains are so much younger than their chronological age, they could be hiding the secrets to treating dementia ...

KANSAS CITY - Cingulate Inc. (NASDAQ:CING), a small-cap biotech company with a market capitalization of $22.16 million, has received a fiscal year 2025 PDUFA fee waiver from the U.S. Food and Drug ...

Cingulate’s lead candidate, CTx-1301, utilizes Cingulate’s proprietary PTR drug delivery platform to create a breakthrough, multi-core formulation of the active pharmaceutical ingredient ...

The normal development of social vocal behavior depends on the anterior cingulate cortex and its interaction with the vocal network during early life.

KANSAS CITY - Biopharmaceutical company Cingulate Inc. (NASDAQ:CING), a micro-cap firm valued at $19.15 million, has appointed Nilay Patel as Chief Legal Officer as the company prepares to submit a ...

Cingulate Inc. completes FDA Pre-NDA meeting for ADHD drug CTx-1301 and secures $3 million grant for anxiety treatment CTx-2103.

The anterior cingulate cortex (ACC) is essential for social behavior, and its dysfunction is implicated in social interaction deficits in autism. Pyramidal neuron activity in the ACC is modulated by ...

Cingulate Inc., a pharmaceutical company listed on the Nasdaq Capital Market under the ticker CING, disclosed today an event involving its CEO, Shane Schaffer. On September 23, 2024, Schaffer was ...

However, only an estimated 20 percent receive treatment. About CTx-1301 Cingulate’s lead candidate, CTx-1301, utilizes Cingulate’s proprietary PTR drug delivery platform to create a breakthrough, ...